Results 41 to 50 of about 13,651 (209)

Efficacy and Safety of Various First-Line Therapeutic Strategies for Fetal Tachycardias: A Network Meta-Analysis and Systematic Review

Frontiers in Pharmacology, 2022
Background: Fetal arrhythmias are common cardiac abnormalities associated with high mortality due to ventricular dysfunction and heart failure, particularly when accompanied by hydrops.
Jiangwei Qin, Zhengrong Deng, Changqing Tang, Yunfan Zhang, Ruolan Hu, Jiawen Li, Yimin Hua, Yifei Li   +7 more
doaj   +1 more source

Fetal tachycardia: A role for amiodarone as first- or second-line therapy? [PDF]

, 2008
SummaryBackgroundFetal tachycardias result in serious prenatal and postnatal morbidity and mortality. Intrauterine treatment can improve prognosis dramatically and the therapeutic protocol is well defined.
Pézard, Philippe Georges, Boussion, Françoise, Sentilhes, Loïc, Lépinard, Catherine, Couvreur, Marie-Hélène, Victor, Jacques, Geslin, Philippe, Descamps, Philippe   +7 more
core   +4 more sources

Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial [PDF]

, 2017
Introduction Several retrospective or single-centrestudies demonstrated the efficacy of transplacentaltreatment of fetal tachyarrhythmias. Our retrospectivenationwide survey showed that the fetal therapy willbe successful at an overall rate of 90%.
Hagiwara Akiko, Hamasaki Toshimitsu, Horigome Hitoshi, Ikeda Tomoaki, Inamura Noboru, Kato Hitoshi, Katsuragi Shinji, Kawataki Motoyoshi, Maeno Yasuki, Miyoshi Takekazu, Nii Masaki, Sago Haruhiko, Sakaguchi Heima, Shimizu Wataru, Shiraishi Isao, Shozu Makio, Taketazu Mio, Ueda Keiko, Yamamoto Haruko, Yasukochi Satoshi, Yoda Hitoshi, 堀米 仁志   +21 more
core   +1 more source

Drug Critical Limits for Urgent Physician Notification

Clinical Pharmacology &Therapeutics, EarlyView.
Critical limits represent quantitative decision thresholds for drugs that require immediate clinician notification and potential life‐saving intervention. United States hospitals lack a national standard for drug critical limits. We collected critical limits from 417 US hospitals across all 50 states and Washington, D.C.; of these, 411 maintained drug ...
Elina Kuang, Yasmeen Ibrahim, Kyle Cheng, Gerald J. Kost   +3 more
wiley   +1 more source

Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation. [PDF]

PLoS ONE, 2010
BACKGROUND: Antiarrhythmic action of flecainide is based on sodium channel blockade. Beta(1)-adrenoceptor (beta(1)AR) activation induces sodium channel inhibition, too.
Amir M Nia, Evren Caglayan, Natig Gassanov, Tom Zimmermann, Orhan Aslan, Martin Hellmich, Firat Duru, Erland Erdmann, Stephan Rosenkranz, Fikret Er   +9 more
doaj   +1 more source

Connexin-dependent neuroglial networking as a new therapeutic target [PDF]

, 2017
Astrocytes and neurons dynamically interact during physiological processes, and it is now widely accepted that they are both organized in plastic and tightly regulated networks.
Christian C. Naus, Christian Giaume, Juan C. Sáez, Juan C. Sáez, Luc Leybaert, Mathieu Charvériat   +5 more
core   +2 more sources

Recreational Drug Use at a Music Festival: A Dual Approach Using Hair Biomarkers Analysis and Participant Self‐Reported Drug Use

Drug Testing and Analysis, EarlyView.
Combined self‐report and hair analysis in festival attendees (n = 249) revealed substantial discrepancies in drug use reporting, particularly for stimulants and dissociatives. This integrated approach enhances detection of poly‐drug use and provides a more reliable basis for monitoring and harm‐reduction strategies.
A. Y. Simão, T. Rosado, M. Barroso, M. Andraus, E. Gallardo   +4 more
wiley   +1 more source

Paroxysmal atrial fibrillation recurrences and quality of life in symptomatic patients: A crossover study of flecainide and pilsicainide

Journal of Arrhythmia, 2017
Background: The therapeutic goals of atrial fibrillation (AF) patients are to reduce symptoms and prevent severe complications associated with AF. This study compared the efficacy of flecainide versus pilsicainide in reducing the frequency of AF and ...
Tsuyoshi Shiga, Koichiro Yoshioka, Eiichi Watanabe, Hisako Omori, Masahiro Yagi, Yasuo Okumura, Naoki Matsumoto, Kengo Kusano, Chikara Oshiro, Takanori Ikeda, Naohiko Takahashi, Takashi Komatsu, Atsushi Suzuki, Tsuyoshi Suzuki, Yasuto Sato, Takeshi Yamashita   +15 more
doaj   +1 more source

Systemic medications associate with surgically treated cataract among adults over 50 years in Finland

Acta Ophthalmologica, EarlyView.
Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen, Jari Haukka, Tuomas Lilius, Sirpa Loukovaara   +3 more
wiley   +1 more source

Systems Pharmacology [PDF]

, 2008
The slides are from a presentation given by Professor Ravi Iyengar from Mount Sinai School of Medicine at the Drug Forum Meeting #9 that took place in Washington, DC on February 20-21, 2008.
Ravi Iyengar
core   +2 more sources